0

Journal Articles

in Lipids and Lipid Disorders
 81-100 of 807 Articles
JAMA Pediatrics | 
Special Feature |  December 01, 2011 FREE
Picture of the Month—Diagnosis
Arch Pediatr Adolesc Med. 2011;165(12):1132. doi:10.1001/archpediatrics.2011.190-b.
JAMA Internal Medicine | 
Original Investigation |  November 28, 2011 FREE
Improving Care After Myocardial Infarction Using a 2-Year Internet-Delivered Intervention:  The Department of Veterans Affairs Myocardial Infarction–Plus Cluster-Randomized Trial
Deborah A. Levine, MD, MPH; Ellen M. Funkhouser, DrPH; Thomas K. Houston, MD, MPH; et al.
Arch Intern Med. 2011;171(21):1910-1917. doi:10.1001/archinternmed.2011.498.
INCLUDES: , Supplemental Content
JAMA | 
Commentary |  November 16, 2011
Cardiovascular Science in the Service of National Strength
JAMA. 2011;306(19):2145-2146. doi:10.1001/jama.2011.1669.
JAMA | 
Commentary |  November 16, 2011
The Cardiovascular Biomarker Conundrum:  Challenges and Solutions
Vinay Prasad, MD; Robert O. Bonow, MD
JAMA. 2011;306(19):2151-2152. doi:10.1001/jama.2011.1673.
JAMA | 
Editorial |  November 16, 2011
High-Density Lipoprotein Cholesterol as the Holy Grail
Christopher P. Cannon, MD
JAMA. 2011;306(19):2153-2155. doi:10.1001/jama.2011.1687.
JAMA | 
Original Contribution |  November 16, 2011 FREE
Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol:  A Randomized Controlled Trial
Stephen J. Nicholls, MBBS, PhD; H. Bryan Brewer, MD, PhD; John J. P. Kastelein, MD, PhD; et al.
JAMA. 2011;306(19):2099-2109. doi:10.1001/jama.2011.1649.
INCLUDES: , Supplemental Content
JAMA | 
Medical News and Perspectives |  November 16, 2011
Statin Therapy in Primary CVD Prevention Remains a Hot-button Topic for Some
JAMA. 2011;306(19):2077-2078. doi:10.1001/jama.2011.1664.
JAMA Neurology | 
Neurological Review |  November 01, 2011 FREE
Cholesterol Level and Statin Use in Alzheimer Disease:  II. Review of Human Trials and Recommendations
Nina E. Shepardson, MS; Ganesh M. Shankar, MD, PhD; Dennis J. Selkoe, MD
Arch Neurol. 2011;68(11):1385-1392. doi:10.1001/archneurol.2011.242.
JAMA Internal Medicine | 
Original Investigation |  October 24, 2011 FREE
Shared Electronic Vascular Risk Decision Support in Primary Care:  Computerization of Medical Practices for the Enhancement of Therapeutic Effectiveness (COMPETE III) Randomized Trial
Anne Holbrook, MD, PharmD, MSc, FRCPC; Eleanor Pullenayegum, PhD; Lehana Thabane, PhD; et al.
Arch Intern Med. 2011;171(19):1736-1744. doi:10.1001/archinternmed.2011.471.
JAMA | 
Caring for the Critically Ill Patient |  October 12, 2011 FREE
Enteral Omega-3 Fatty Acid, γ-Linolenic Acid, and Antioxidant Supplementation in Acute Lung Injury
Todd W. Rice, MD, MSc; Arthur P. Wheeler, MD; B. Taylor Thompson, MD; et al.
JAMA. 2011;306(14):1574-1581. doi:10.1001/jama.2011.1435.
INCLUDES: , Supplemental Content
JAMA Neurology | 
Clinical Trials |  October 01, 2011 FREE
Risk of Stroke and Cardiovascular Events After Ischemic Stroke or Transient Ischemic Attack in Patients With Type 2 Diabetes or Metabolic Syndrome:  Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
Alfred Callahan, MD; Pierre Amarenco, MD; Larry B. Goldstein, MD; et al.
Arch Neurol. 2011;68(10):1245-1251. doi:10.1001/archneurol.2011.146.
JAMA Neurology | 
Neurological Review |  October 01, 2011 FREE
Cholesterol Level and Statin Use in Alzheimer Disease:  I. Review of Epidemiological and Preclinical Studies
Nina E. Shepardson, MS; Ganesh M. Shankar, MD, PhD; Dennis J. Selkoe, MD
Arch Neurol. 2011;68(10):1239-1244. doi:10.1001/archneurol.2011.203.
JAMA Internal Medicine | 
Invited Commentary |  September 26, 2011
When It Comes to Primary Care, More May Be More:  Comment on “Encounter Frequency and Serum Glucose Level, Blood Pressure, and Cholesterol Level Control in Patients With Diabetes Mellitus”
Allan H. Goroll, MD, MACP
Arch Intern Med. 2011;171(17):1550-1551. doi:10.1001/archinternmed.2011.403.
JAMA Internal Medicine | 
Research Letters |  September 26, 2011 FREE
Making the Case for Selective Use of Statins in the Primary Prevention Setting
C. Michael Minder, MD; Michael J. Blaha, MD, MPH; Lori M. Tam, MD; et al.
Arch Intern Med. 2011;171(17):1593-1594. doi:10.1001/archinternmed.2011.349.
JAMA Internal Medicine | 
Original Investigation |  September 26, 2011 FREE
Encounter Frequency and Serum Glucose Level, Blood Pressure, and Cholesterol Level Control in Patients With Diabetes Mellitus
Fritha Morrison, MPH; Maria Shubina, ScD; Alexander Turchin, MD, MS
Arch Intern Med. 2011;171(17):1542-1550. doi:10.1001/archinternmed.2011.400.
JAMA | 
Preliminary Communication |  September 14, 2011 FREE
Association Between Serum Cathepsin S and Mortality in Older Adults
Elisabeth Jobs, MSc; Erik Ingelsson, MD, PhD; Ulf Risérus, MMed, PhD; et al.
JAMA. 2011;306(10):1113-1121. doi:10.1001/jama.2011.1246.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Original Investigation |  September 12, 2011 FREE
Team-Based Care Approach to Cholesterol Management in Diabetes Mellitus:  Two-Year Cluster Randomized Controlled Trial
Ginger A. Pape, PharmD, BCPS; Jacquelyn S. Hunt, PharmD, MS; Kristina L. Butler, PharmD, BCPS; et al.
Arch Intern Med. 2011;171(16):1480-1486. doi:10.1001/archinternmed.2011.417.
JAMA Internal Medicine | 
Review Article |  September 12, 2011 FREE
Impact of Pharmacist Care in the Management of Cardiovascular Disease Risk Factors:  A Systematic Review and Meta-analysis of Randomized Trials
Valérie Santschi, PharmD, PhD; Arnaud Chiolero, MD, MSc; Bernard Burnand, MD, MPH; et al.
Arch Intern Med. 2011;171(16):1441-1453. doi:10.1001/archinternmed.2011.399.
JAMA | 
Original Contribution |  August 24, 2011 FREE
Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia:  A Randomized Controlled Trial
David J. A. Jenkins, MD; Peter J. H. Jones, PhD; Benoit Lamarche, PhD; et al.
JAMA. 2011;306(8):831-839. doi:10.1001/jama.2011.1202.
INCLUDES: , Supplemental Content
JAMA | 
The World in Medicine |  July 20, 2011
Lipid Remodeling and Obesity
M. J. Friedrich
JAMA. 2011;306(3):257. doi:10.1001/jama.2011.962.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 6, 2013
Two New Drugs for Homozygous Familial Hypercholesterolemia:  Managing Benefits and Risks in a Rare Disorder
Robert J. Smith, MD; William R. Hiatt, MD
JAMA Internal Medicine
Research Letters  |  April 29, 2013
Limit to Benefits of Large Reductions in Low-Density Lipoprotein Cholesterol Levels: Use of Fractional Polynomials to Assess the Effect of Low-Density Lipoprotein Cholesterol Level Reduction in Metaregression of Large Statin Randomized Trials
Hisato Takagi, MD, PhD; Takuya Umemoto, MD, PhD; for the ALICE (All-Literature Investigation of Cardiovascular Evidence) Group
JAMA Internal Medicine
Invited Commentary  |  March 4, 2013
Getting to the Heart of HIV and Myocardial Infarction:  Comment on “HIV Infection and the Risk of Acute Myocardial Infarction”
Patrick W. G. Mallon, MB, BCh, PhD, FRACP, FRCPI
JAMA Internal Medicine
Research Letters  |  April 08, 2013
A National Survey of the Treatment of Hyperlipidemia in Primary Prevention
Michael E. Johansen, MD; Katherine J. Gold, MD, MSW, MS; Ananda Sen, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems